OpenURL Connection Search

Select item for more details and to access through your institution.

The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia.
Published in:
2011
By:
- Razga, Filip;
- Racil, Zdenek;
- Machova Polakova, Katerina;
- Buresova, Lucie;
- Klamova, Hana;
- Zackova, Daniela;
- Dvorakova, Dana;
- Polivkova, Vaclava;
- Cetkovsky, Petr;
- Mayer, Jiri
Publication type:
Letter
Unstable major molecular response as a trigger for next generation sequencing‐based BCR::ABL1 mutation testing in chronic myeloid leukemia.
Published in:
American Journal of Hematology, 2024, v. 99, n. 4, p. 759, doi. 10.1002/ajh.27232
By:
- Benesova, Adela;
- De Santis, Sara;
- Polivkova, Vaclava;
- Pecherkova, Pavla;
- Krizkova, Jitka;
- Suchankova, Pavla;
- Monaldi, Cecilia;
- Klamova, Hana;
- Srbova, Dana;
- Zizkova, Hana;
- Hochhaus, Andreas;
- Soverini, Simona;
- Machova Polakova, Katerina
Publication type:
Article
Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.744373
By:
- Curik, Nikola;
- Polivkova, Vaclava;
- Burda, Pavel;
- Koblihova, Jitka;
- Laznicka, Adam;
- Kalina, Tomas;
- Kanderova, Veronika;
- Brezinova, Jana;
- Ransdorfova, Sarka;
- Karasova, Dominika;
- Rejlova, Katerina;
- Bakardjieva, Marina;
- Kuzilkova, Daniela;
- Kundrat, David;
- Linhartova, Jana;
- Klamova, Hana;
- Salek, Cyril;
- Klener, Pavel;
- Hrusak, Ondrej;
- Machova Polakova, Katerina
Publication type:
Article
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0523-3
By:
- Jaruskova, Monika;
- Curik, Nikola;
- Hercog, Rajna;
- Polivkova, Vaclava;
- Motlova, Eliska;
- Benes, Vladimir;
- Klamova, Hana;
- Pecherkova, Pavla;
- Belohlavkova, Petra;
- Vrbacky, Filip;
- Polakova, Katerina Machova
Publication type:
Article
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients.
Published in:
Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02053-4
By:
- Hovorkova, Lenka;
- Winkowska, Lucie;
- Skorepova, Justina;
- Krumbholz, Manuela;
- Benesova, Adela;
- Polivkova, Vaclava;
- Alten, Julia;
- Bardini, Michela;
- Meyer, Claus;
- Kim, Rathana;
- Trahair, Toby N.;
- Clappier, Emmanuelle;
- Chiaretti, Sabina;
- Henderson, Michelle;
- Sutton, Rosemary;
- Sramkova, Lucie;
- Stary, Jan;
- Polakova, Katerina Machova;
- Marschalek, Rolf;
- Metzler, Markus
Publication type:
Article
Exosomes released by imatinib-resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib-sensitive cells in the presence of imatinib.
Published in:
International Journal of Oncology, 2021, v. 58, n. 2, p. 238
By:
- Hrdinova, Tereza;
- Toman, Ondrej;
- Dresler, Jiri;
- Klimentova, Jana;
- Salovska, Barbora;
- Pajer, Petr;
- Bartos, Oldrich;
- Polivkova, Vaclava;
- Linhartova, Jana;
- Polakova, Katerina Machova;
- Kabickova, Hana;
- Brodska, Barbora;
- Krijt, Matyas;
- Zivny, Jan;
- Vyoral, Daniel;
- Petrak, Jiri
Publication type:
Article
Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients.
Published in:
PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155959
By:
- Polivkova, Vaclava;
- Rohon, Peter;
- Klamova, Hana;
- Cerna, Olga;
- Divoka, Martina;
- Curik, Nikola;
- Zach, Jan;
- Novak, Martin;
- Marinov, Iuri;
- Soverini, Simona;
- Faber, Edgar;
- Machova Polakova, Katerina
Publication type:
Article

Found: 7

The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia.

Unstable major molecular response as a trigger for next generation sequencing‐based BCR::ABL1 mutation testing in chronic myeloid leukemia.

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining.

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.

Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients.

Exosomes released by imatinib-resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib-sensitive cells in the presence of imatinib.

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients.